These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 32171323

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial.
    Sha Z, Hou Y, Xue C, Li O, Li Z, Wang H, Zhang W, Xu J.
    Trials; 2020 Jan 23; 21(1):107. PubMed ID: 31973702
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial.
    Park DM, Kim SH, Park YC, Kang WC, Lee SR, Jung IC.
    J Ethnopharmacol; 2014 Dec 02; 158 Pt A():11-7. PubMed ID: 25456420
    [Abstract] [Full Text] [Related]

  • 6. Effects of Jie Yu Wan on Generalized Anxiety Disorder: A Randomized Clinical Trial.
    Li X, Zheng S, Feng S, Ma R, Jia Y, Zhao A, Wei D, Guo H, Duan N, Ding Y, Chen J, Zhu H, Jia H.
    Evid Based Complement Alternat Med; 2022 Dec 02; 2022():9951693. PubMed ID: 35432560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR, DuPont RL, Hedges D, Haskins JT.
    J Clin Psychiatry; 1999 Aug 02; 60(8):528-35. PubMed ID: 10485635
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
    Shen Z, Zheng K, Zou J, Gu P, Xing J, Zhang L, Zhu L, Shen H.
    Trials; 2021 Jan 13; 22(1):55. PubMed ID: 33441157
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of Qing-Feng-Gan-Ke Granules in patients with postinfectious cough: study protocol of a novel-design phase III placebo-controlled, double-blind randomized trial.
    Liu W, Jiang H, Zhang R, Jin F, Liu L, Long Y, Cui L, Li S, Zhong Y, Mao B.
    BMC Complement Altern Med; 2015 Aug 19; 15():290. PubMed ID: 26286147
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy of Shugan granule in the treatment of mixed anxiety-depressive disorder: A multicenter, randomized, double-blind, placebo-controlled trial.
    Li Y, Li L, Guo R, Yu H, Wang X, Wang B, Wang Q, Li Z, Zhao H, Temu Q, Chen X, Zhang Y, An J, Cai X, Li A, Qi L, Shang J, He H, Yang D, Lin J, Zhang Y, Zou T.
    J Ethnopharmacol; 2022 May 23; 290():115032. PubMed ID: 35085742
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec 23; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
    Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J.
    J Clin Psychopharmacol; 2009 Aug 23; 29(4):378-82. PubMed ID: 19593179
    [Abstract] [Full Text] [Related]

  • 16. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 17. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec 06; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM, Spadone C, Sol O, Danniau A, Bougerol T, Corruble E, Faruch M, Macher JP, Sermet E, Servant D.
    J Clin Psychiatry; 2002 Nov 06; 63(11):1020-7. PubMed ID: 12444816
    [Abstract] [Full Text] [Related]

  • 19. Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients (CheruPDYS): a study protocol for a randomized placebo-controlled trial.
    Li G, Zhang Z, Zhou L, Liao S, Sun J, Liu Y, Wang X, Wen Z.
    Trials; 2021 Jan 26; 22(1):95. PubMed ID: 33499921
    [Abstract] [Full Text] [Related]

  • 20. Effects of sang-qi granules on blood pressure and endothelial dysfunction in stage I or II hypertension: study protocol for a randomized double-blind double-simulation controlled trial.
    Shi H, Yang D, Qiao J, Sun R, Li R, Zhu C, Jing R, Liu L, Huang L, Li L.
    Trials; 2020 Jan 06; 21(1):12. PubMed ID: 31907056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.